Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance system

A program to detect defective drugs in the postmarketing period

Rev Panam Salud Publica;6(3),sept. 1999

Qualidade dos Medicamentos Homeopáticos; Determinação; Vigilância de Produtos Comercializados

(1999) Programa de detección de fallas de calidad en los medicamentos comercializados. Rev Panam Salud Publica;6(3) -,sept. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=iso